Anthem Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	-	2,729	1,714	1,839	3,422	3,418
Short-Term Investments	-	-	-	-	4,929	2,691
Trading Asset Securities	-	6,656	3,123	4,591	-	-
Cash & Short-Term Investments	9,385	9,385	4,837	6,429	8,351	6,109
Cash Growth	28.16%	94.01%	-24.76%	-23.01%	36.70%	148.94%
Accounts Receivable	-	5,906	4,504	4,904	2,741	3,262
Other Receivables	-	29.15	95.15	1.96	12.15	73.23
Receivables	-	5,935	4,599	4,906	2,753	3,335
Inventory	-	1,245	3,404	2,113	1,294	582.3
Prepaid Expenses	-	45.71	2.14	31.67	19.43	25.04
Other Current Assets	-	1,421	2,039	1,335	814.18	881.44
Total Current Assets	-	18,031	14,882	14,816	13,232	10,933
Property, Plant & Equipment	-	10,471	9,981	8,210	6,039	4,759
Long-Term Investments	-	3,419	1,208	125.53	61.6	36.96
Other Intangible Assets	-	4.41	38.71	62.43	90.89	68.99
Long-Term Accounts Receivable	-	31.08	31.12	31.08	31.08	31.12
Long-Term Deferred Tax Assets	-	273.22	179.47	413.95	249.08	159.38
Other Long-Term Assets	-	1,990	1,701	249.73	370.15	127.81
Total Assets	-	34,293	28,076	23,981	20,145	16,189

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	-	752.17	1,101	1,007	719.41	648.41
Accrued Expenses	-	606.66	252.29	308.02	249.82	245.63
Short-Term Debt	-	43.6	429.52	817.96	87.46	274.93
Current Portion of Long-Term Debt	-	189.74	189.74	390.71	201.3	11.5
Current Portion of Leases	-	19.73	15.06	16.85	3.22	21.22
Current Income Taxes Payable	-	373.05	230.27	64.11	58.83	193.89
Current Unearned Revenue	-	-	-	-	3.85	-
Other Current Liabilities	-	1,272	1,045	781.21	314.81	866.29
Total Current Liabilities	-	3,257	3,262	3,386	1,639	2,262
Long-Term Debt	-	277.34	470.28	1,117	961.88	245.8
Long-Term Leases	-	8.83	28.56	43.06	7.64	24.39
Long-Term Unearned Revenue	-	7	9.34	11.69	14.18	16.64
Pension & Post-Retirement Benefits	-	163.03	43.87	39.78	33.6	31.99
Other Long-Term Liabilities	-	154.4	162.81	137.21	81.89	57.99
Total Liabilities	-	3,868	3,977	4,735	2,738	2,639

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Common Stock	-	1,123	1,118	1,118	1,141	87.76
Additional Paid-In Capital	-	1,512	1,252	1,252	2,719	2,700
Retained Earnings	-	27,479	21,392	16,879	13,570	10,726
Comprehensive Income & Other	-	311	336.79	-2.72	-23.05	35.82
Shareholders' Equity	30,425	30,425	24,099	19,247	17,407	13,550
Total Liabilities & Equity	-	34,293	28,076	23,981	20,145	16,189

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	539.24	539.24	1,133	2,385	1,262	577.84
Net Cash (Debt)	8,846	8,846	3,704	4,044	7,090	5,531
Net Cash Growth	42.91%	138.80%	-8.41%	-42.96%	28.17%	286.71%
Net Cash Per Share	15.53	15.59	6.60	7.13	12.43	9.70
Filing Date Shares Outstanding	563.1	561.71	561.61	559.08	570.49	570.46
Total Common Shares Outstanding	563.1	561.71	559.08	559.08	570.49	570.46
Working Capital	-	14,774	11,619	11,429	11,593	8,671
Book Value Per Share	54.16	54.16	43.10	34.43	30.51	23.75
Tangible Book Value	30,421	30,421	24,060	19,184	17,316	13,481
Tangible Book Value Per Share	54.16	54.16	43.04	34.31	30.35	23.63
Land	-	836.13	836.13	836.13	836.13	836.13
Buildings	-	3,432	3,239	2,012	1,579	1,304
Machinery	-	10,467	8,595	6,761	6,137	4,632
Construction In Progress	-	2,643	2,969	3,447	1,641	1,538